Catalyst Pharmaceuticals
CPRX
#3738
Rank
A$4.35 B
Marketcap
$36.50
Share price
-0.13%
Change (1 day)
58.92%
Change (1 year)

Earnings for Catalyst Pharmaceuticals (CPRX)

Earnings in 2024 (TTM): A$0.27 Billion

According to Catalyst Pharmaceuticals's latest financial reports the company's current earnings are A$0.46 Billion. In 2023 the company made an earning of A$0.15 Billion a decrease over its 2022 earnings that were of A$0.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Catalyst Pharmaceuticals from 2007 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) A$0.27 B85.26%
2023 A$0.15 B-9.75%
2022 A$0.16 B98.83%
2021 A$83.99 M25.73%
2020 A$66.8 M25.38%
2019 A$53.27 M-198.25%
2018 -A$54.23 Million84.68%
2017 -A$29.37 Million1.88%
2016 -A$28.83 Million-10.68%
2015 -A$32.27 Million30.46%
2014 -A$24.74 Million27.6%
2013 -A$19.39 Million198.17%
2012 -A$6.51 Million-36.22%
2011 -A$10.2 Million59.52%
2010 -A$6.39 Million-44.68%
2009 -A$11.55 Million-31.45%
2008 -A$16.85 Million155.21%
2007 -A$6.61 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$0.62 B 107.35%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.20 B-31.46%๐Ÿ‡บ๐Ÿ‡ธ USA
A$29.33 B 9,643.68%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.44 Billion-243.96%๐Ÿ‡บ๐Ÿ‡ธ USA
A$11.07 B 3,577.65%๐Ÿ‡บ๐Ÿ‡ธ USA
A$10.80 B 3,490.25%๐Ÿ‡บ๐Ÿ‡ธ USA